What BeOne Medicines AG's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 53 | 204 |
| Total trades | 61 | 284 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 284 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Wang Xiaodong | Director | Oct 13 | Open-market sale · S | −1,260 | $353.24 | −$445K | 0 |
| Wang Xiaodong | Director | Oct 13 | Open-market sale · S | −6,558 | $352.57 | −$2.31M | 1,260 |
| Wang Xiaodong | Director | Oct 13 | Open-market sale · S | −5,681 | $351.40 | −$2M | 7,818 |
| Wang Xiaodong | Director | Oct 13 | Open-market sale · S | −10,361 | $350.47 | −$3.63M | 13,499 |
| Wang Xiaodong | Director | Oct 13 | Open-market sale · S | −7,167 | $349.56 | −$2.51M | 23,860 |
| Wang Xiaodong | Director | Oct 13 | Exercise / conversion · M | +31,027 | $36.90 | +$1.14M | 31,027 |
| Lee Chan Henry | SVP, General Counsel | Sep 30 | Open-market sale · S | −1,115 | $375.00 | −$418K | 0 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −738 | $367.23 | −$271K | 0 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −14,525 | $366.58 | −$5.32M | 738 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −2,047 | $365.85 | −$749K | 15,263 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −3,419 | $364.07 | −$1.24M | 17,310 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −3,499 | $363.10 | −$1.27M | 20,729 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −4,239 | $362.17 | −$1.54M | 24,228 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −2,241 | $361.05 | −$809K | 28,467 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −40 | $359.16 | −$14.4K | 30,708 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −120 | $358.71 | −$43K | 30,748 |
| Wang Xiaodong | Director | Sep 28 | Open-market sale · S | −160 | $356.97 | −$57.1K | 30,868 |
| Wang Xiaodong | Director | Sep 28 | Exercise / conversion · M | +31,028 | $36.90 | +$1.14M | 31,028 |
| Baker Bros. Advisors Lp | Director | Sep 14 | Exercise / conversion · M | +30,768 | $36.83 | +$1.13M | 8,099,179 |
| Baker Bros. Advisors Lp | Director | Sep 14 | Exercise / conversion · M | +30,768 | $36.83 | +$1.13M | 761,410 |
Loading...